Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Low zinc levels may contribute to hair loss due to increased oxidative DNA damage.

Low zinc levels in chronic liver disease patients are linked to more severe symptoms like taste issues and skin problems, and zinc supplements might help.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

The luliconazole shampoo effectively reduces symptoms of seborrheic dermatitis and is well-tolerated.

Gene expression in hair follicles can help diagnose methamphetamine use disorder.

A diabetes-informed approach is essential for safe and effective skin rejuvenation treatments in diabetics.

The improved tretinoin lotion effectively treats acne with minimal irritation, even in children as young as 9.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Pharmacist-led care significantly improved post-COVID symptoms.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

A ketogenic diet helps reduce weight, BMI, waist size, and fat in overweight women with PCOS.

A new, quick method accurately detects minoxidil in drugs and cosmetics.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.